Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine Taleb

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Diabetes, Obesity & Metabolism|September 16, 2016
Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic useNadine Taleb, Ahmad Haidar, Virginie Messier, et al.
Journal of Diabetes Science and Technology|August 15, 2019
Artificial Pancreas Systems and Physical Activity in Patients with Type 1 Diabetes: Challenges, Adopted Approaches, and Future PerspectivesSémah Tagougui, Nadine Taleb, Joséphine Molvau, et al.
Annals of Saudi Medicine|November 18, 2008
Prevalence and determinants of albuminuria in a cohort of diabetic patients in LebanonNadine Taleb, Haytham Salti, Mona Al-Mokaddam, et al.
Diabetes Technology & Therapeutics|August 29, 2017
Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical UseNadine Taleb, Adèle Coriati, Christian Khazzaka, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 28, 2020
Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online surveyNadine Taleb, Ariane Quintal, Rohan Rakheja, et al.
Diabetes Technology & Therapeutics|May 3, 2019
Changes in Accuracy of Continuous Glucose Monitoring Using Dexcom G4 Platinum Over the Course of Moderate Intensity Aerobic Exercise in Type 1 DiabetesStéphanie Larose, Rémi Rabasa-Lhoret, Amélie Roy-Fleming, et al.
Diabetes Technology & Therapeutics|June 30, 2018
Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A ReviewLisa Bonato, Nadine Taleb, Véronique Gingras, et al.
Annales D'Endocrinologie|December 10, 2016
Relative contribution of muscle and liver insulin resistance to dysglycemia in postmenopausal overweight and obese women: A MONET group studyBelinda Elisha, Emmanuel Disse, Katherine Chabot, et al.
Diabetes Technology & Therapeutics|June 30, 2016
Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During ExerciseNadine Taleb, Ali Emami, Corinne Suppere, et al.
Canadian Journal of Diabetes|March 21, 2021
Minimizing the Risk of Exercise-Induced Glucose Fluctuations in People Living With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion: An Overview of StrategiesJoséphine Molveau, Rémi Rabasa-Lhoret, Nadine Taleb, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Diabetes, Obesity & Metabolism|September 16, 2016
Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic useNadine Taleb, Ahmad Haidar, Virginie Messier, et al.
Journal of Diabetes Science and Technology|August 15, 2019
Artificial Pancreas Systems and Physical Activity in Patients with Type 1 Diabetes: Challenges, Adopted Approaches, and Future PerspectivesSémah Tagougui, Nadine Taleb, Joséphine Molvau, et al.
Annals of Saudi Medicine|November 18, 2008
Prevalence and determinants of albuminuria in a cohort of diabetic patients in LebanonNadine Taleb, Haytham Salti, Mona Al-Mokaddam, et al.
Diabetes Technology & Therapeutics|August 29, 2017
Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical UseNadine Taleb, Adèle Coriati, Christian Khazzaka, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 28, 2020
Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online surveyNadine Taleb, Ariane Quintal, Rohan Rakheja, et al.
Diabetes Technology & Therapeutics|May 3, 2019
Changes in Accuracy of Continuous Glucose Monitoring Using Dexcom G4 Platinum Over the Course of Moderate Intensity Aerobic Exercise in Type 1 DiabetesStéphanie Larose, Rémi Rabasa-Lhoret, Amélie Roy-Fleming, et al.
Diabetes Technology & Therapeutics|June 30, 2018
Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A ReviewLisa Bonato, Nadine Taleb, Véronique Gingras, et al.
Annales D'Endocrinologie|December 10, 2016
Relative contribution of muscle and liver insulin resistance to dysglycemia in postmenopausal overweight and obese women: A MONET group studyBelinda Elisha, Emmanuel Disse, Katherine Chabot, et al.
Diabetes Technology & Therapeutics|June 30, 2016
Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During ExerciseNadine Taleb, Ali Emami, Corinne Suppere, et al.
Canadian Journal of Diabetes|March 21, 2021
Minimizing the Risk of Exercise-Induced Glucose Fluctuations in People Living With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion: An Overview of StrategiesJoséphine Molveau, Rémi Rabasa-Lhoret, Nadine Taleb, et al.
Pageof 4